Login to Your Account



Pharma: Other News To Note


Friday, September 13, 2013
• Breckenridge Pharmaceutical Inc., of Boca Raton, Fla., said it completed its acquisition of certain Cypress Pharmaceutical Inc. product assets from Pernix Therapeutics Inc., of The Woodlands, Texas, including 11 abbreviated new drug applications (ANDAs) filed with the FDA, certain ANDAs in various stages of development, as well as six already-approved and marketed products.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription